STEVENSON, Md., Jan. 12, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Fitbit, Inc. (NYSE:FIT) (“Fitbit” or the “Company”) securities during the period between June 18, 2015 and January 6, 2016, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until March 11, 2016 to seek appointment as lead plaintiff.
If you have suffered a loss from investment in Fitbit, Inc. securities purchased on or after June 18, 2015 and held through the revelation of negative information during and/or at the end of the Class Period, as described below, and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. No class has yet been certified in the above action. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.
If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Company securities during the Class Period. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Fitbit’s heart rate monitoring technology was inaccurate and did not consistently deliver accurate heart rate readings during exercise posing serious health risks to users of Fitbit’s products.
According to the complaint, following the disclosure of this defect in a consumer class action filed on January 6, 2016, the value of Fitbit shares declined significantly.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Shell M&A Chief Exits After BP Takeover Proposal Rejected
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



